Dynamic monitoring of serum specific tumor markers predicts the response to PD-1 blockade and prognosis of patients with malignant tumors

BACKGROUND: Programmed cell death protein 1 (PD-1) blockade is a major advance in the treatment of malignancies, but there remain many problems in efficacy evaluation. The aim of this study was to determine whether dynamic monitoring of serum specific tumor markers (SSTMs) could predict the response...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qian, Sun, Xin, Zhou, Yang, Diao, Yan-Wen, Ran, Jia-Ling, Zhang, Jing-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798872/
https://www.ncbi.nlm.nih.gov/pubmed/35116409
http://dx.doi.org/10.21037/tcr-20-2560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798872/
https://www.ncbi.nlm.nih.gov/pubmed/35116409
http://dx.doi.org/10.21037/tcr-20-2560

Ejemplares similares